{"schema":"hottub-news/story/v1","story":"st_urmvztkpwwdnwvgzwjqq","title":"Disparity in Anti-Amyloid Eligibility Seen in Atypical Alzheimer Disease","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/disparity-in-anti-amyloid-eligibility-seen-in-atypical-alzheimer-disease-urmvztkpww","count":1,"items":[{"id":"n_urmvztkpwwdnwvgzwjqq","seq":480566,"kind":"article","title":"Disparity in Anti-Amyloid Eligibility Seen in Atypical Alzheimer Disease","url":"https://www.neurologyadvisor.com/news/atypical-alzheimer-disease-anti-amyloid-therapy-eligibility","published":"2026-09-28T13:29:00Z","seen":"2026-09-28T17:10:21Z","lang":"en","source":{"id":"neurologyadvisor.com","name":"neurologyadvisor.com","domain":"neurologyadvisor.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q11081","name":"Alzheimer's disease","type":"event"}],"story":"st_urmvztkpwwdnwvgzwjqq","category":"health","category_p":0.7599999904632568,"sentiment":"neutral","tone":-0.12999999523162842,"political":0.05000000074505806}]}